STOPPFrail第2版:用于临终前老年人的处方精简工具开发与验证
STOPPFrail标准于2017年制定,用于帮助医生对接近临终的体弱老年人进行处方精简,现需更新以更具实用性、以患者为中心且更全面。通过文献综述和八人专家小组修订草案,并采用德尔菲共识法验证,形成STOPPFrail第2版,强调共享决策,纳入识别可能接近临终老年人的新方法及25条处方精简标准。
要点
- STOPPFrail第2版强调处方精简过程中的共享决策。
- 新方法用于识别可能接近临终的老年人,并含25条处方精简标准。
- 新增抗高血压药、抗心绞痛药和维生素D制剂的处方精简指导。
核心结论
- STOPPFrail标准已更新,以帮助医生减少最体弱老年患者的药物相关疾病负担。
研究设计与样本
- 通过全面文献综述制定识别接近临终老年人的实用方法,并重新评估和更新现有处方精简标准。
- 由八名在老年药物治疗方面经验丰富的专家组成小组审查新草案并提出新标准,随后采用德尔菲共识法验证STOPPFrail第2版。
主要发现
- STOPPFrail第2版强调共享决策在处方精简过程中的重要性。
- 纳入了识别可能接近临终老年人的新方法以及25条处方精简标准。
- 新增抗高血压治疗、抗心绞痛药物和维生素D制剂相关的处方精简指导。
关键数值与推荐
- STOPPFrail第2版包含25条处方精简标准,并新增抗高血压治疗、抗心绞痛药物和维生素D制剂相关指导。
临床怎么用
- 医生可依据STOPPFrail第2版识别可能接近临终的体弱老年人,并在共享决策下精简抗高血压药、抗心绞痛药和维生素D制剂等药物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy (STOPPFrail) criteria were developed in 2017 to assist physicians with deprescribing decisions in older people approaching end-of-life. Updating was required to make the tool more practical, patient-centred and complete. METHODS: a thorough literature review was conducted to, first, devise a practical method for identifying older people who are likely to be approaching end-of-life, and second, reassess and update the existing deprescribing criteria. An eight-member panel with a wide-ranging experience in geriatric pharmacotherapy reviewed a new draft of STOPPFrail and were invited to propose new deprescribing criteria. STOPPFrail version 2 was then validated using Delphi consensus methodology. RESULTS: STOPPFrail version 2 emphasises the importance of shared decision-making in the deprescribing process. A new method for identifying older people who are likely to be approaching end-of-life is included along with 25 deprescribing criteria. Guidance relating to the deprescribing of antihypertensive therapies, anti-anginal medications and vitamin D preparations comprises the new criteria. CONCLUSIONS: STOPPFrail criteria have been updated to assist physicians in efforts to reduce drug-related morbidity and burden for their frailest older patients. Version 2 is based on an up-to-date literature review and consensus validation by a panel of experts.
引用
- Curtin D, Gallagher P, O'Mahony D, et al. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing. 2021. PMID: 32997135. doi:10.1093/ageing/afaa159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。